- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04977258
Different Hydration Strategies Associated With Aerobic Exercise In Coronary
August 9, 2021 updated by: Luiz Carlos Marques Vanderlei, Universidade Estadual Paulista Júlio de Mesquita Filho
Effect of Different Hydration Strategies on Autonomic Acceleration During Recovery in Individuals With Coronary Artery Disease Undergoing Aerobic Exercise
The need to restore water losses resulting from physical activity has become established and diffused into international consensus for healthy individuals or high-performance athletes.
However, the influence of fluid replacement when administered during and after exercise on cardiac autonomic modulation with autonomic alterations known as the coronary arteries remain poorly understood.
The aim of the study was to evaluate and compare whether different hydration strategies are able to promote acceleration of the recovery of autonomic modulation in individuals with coronary artery disease undergoing aerobic exercise.
This study is a cross-over clinical trial, which will be developed based on an experimental procedure performed in four stages.
A total of 31 individuals will be recruited in this study and will perform four standardized cardiovascular rehabilitation (CR) sessions.
The participants will perform CR with mineral water intake in phase three and four.
In phase three, the consumption will be done a quantity of water predetermined by the evaluator, based on the loss of body mass measured in the second session.
In phase four, hydration will be carried out in an uncontrolled manner, according to the desire to drink water during the protocol.
Study Overview
Status
Recruiting
Conditions
Study Type
Interventional
Enrollment (Anticipated)
31
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Lorena Santos, BPT
- Phone Number: 55019992359245
- Email: lorenaltafin@gmail.com
Study Contact Backup
- Name: Luiz Carlos Vanderlei, PhD
- Phone Number: 55018997029639
- Email: lcmvanderlei@fct.unesp.br
Study Locations
-
-
São Paulo
-
Presidente Prudente, São Paulo, Brazil, 19060-900
- Recruiting
- Luiz Carlos Masques Vanderlei
-
Contact:
- Lorena Santos, BPT
- Phone Number: 55019992359245
- Email: lorenaltafin@gmail.com
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
45 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Male
Description
Inclusion Criteria:
- Men with coronary heart disease ischemia, over 45 years
- At least three months of cardiovascular rehabilitation
Exclusion Criteria:
- Smokers, alcoholics
- Uncontrolled metabolic disease (eg, uncontrolled diabetes and thyroid diseases)
- Abnormal hemodynamic responses during exercise such as disproportionate increase / fall of heart rate and / or blood pressure to low / high levels of load
- Myocardial ischemia and / or severe ventricular arrhythmias during the exercise test
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Control group
Only treadmill aerobic exercise with 60 min recovery in supine position.
|
The volunteers will be submitted to a cardiovascular rehabilitation session with 40 minutes of treadmill aerobic exercise followed by 60 minutes of recovery at the supine position.
|
|
Experimental: Controlled hydration group
Treadmill aerobic exercise with 60 min recovery in supine position, with mineral water predetermined intake.
|
The volunteers will be submitted to a cardiovascular rehabilitation session with 40 minutes of treadmill aerobic exercise and water intake followed by 60 minutes of recovery at the supine position.
|
|
Experimental: Ad Libitum hydration group
Treadmill aerobic exercise with 60 min recovery in supine position, with mineral water intake in an uncontrolled manner.
|
The volunteers will be submitted to a cardiovascular rehabilitation session with 40 minutes of treadmill aerobic exercise and water intake followed by 60 minutes of recovery at the supine position.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Heart rate variability
Time Frame: up to six months
|
Linear indices of heart rate variability in the time domain (SDNN, rMSSD).
|
up to six months
|
|
Heart rate variability
Time Frame: up to six months
|
Linear indices of heart rate variability in the frequency domain (HF, LF, LF/HF)
|
up to six months
|
|
Heart rate variability
Time Frame: up to six months
|
Geometric indices of heart rate variability (TINN, RRTRI, SD1, SD2, SD1/SD2)
|
up to six months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Study Director: Luiz Carlos Vanderlei, PhD, Universidade Estadual Paulista - UNESP - Campus de Presidente Prudente
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Anticipated)
August 16, 2021
Primary Completion (Anticipated)
October 26, 2021
Study Completion (Anticipated)
February 26, 2022
Study Registration Dates
First Submitted
July 15, 2021
First Submitted That Met QC Criteria
July 15, 2021
First Posted (Actual)
July 26, 2021
Study Record Updates
Last Update Posted (Actual)
August 11, 2021
Last Update Submitted That Met QC Criteria
August 9, 2021
Last Verified
August 1, 2021
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 34722320.0.0000.5402
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Coronary Disease
-
Scitech Produtos Medicos SANot yet recruitingCoronary Artery Disease (CAD) | Multivessel Coronary Artery Disease | Complex Coronary Lesions | Calcific Coronary Arteriosclerosis | Small Vessel Ischemic Disease | Stenosis CoronaryBrazil
-
OPCI Core Laboratories LLCNot yet recruitingCoronary Artery Disease (CAD) | Coronary Calcification | Coronary Calcified Disease | Coronary Calcified NodulesUnited States
-
Shunmei MedicalNot yet recruitingCalcified Coronary Artery Disease | Coronary Arterial DiseasePoland, France, Spain
-
Kaohsiung Veterans General Hospital.CompletedChronic Coronary Syndrome; Coronary Artery Disease; Percutaneous Coronary InterventionTaiwan
-
University of GalwayNot yet recruitingMyocardial Ischemia | Percutaneous Coronary Intervention | Chronic Coronary Syndrome | Coronary Computed Tomography Angiography | Acute Coronary Syndromes (ACS) | Coronary Arteries Disease
-
Peking Union Medical College HospitalNot yet recruitingCoronary Artery Disease | Percutaneous Coronary Intervention | Coronary Stenosis | Coronary Restenosis | Coronary Artery Disease Progression | Coronary Stent Occlusion | Myocardial Revascularization
-
SUK MIN SEODaewoong Pharmaceutical Co. LTD.RecruitingCoronary Artery Disease (CAD) | Acute Coronary Syndromes (ACS)South Korea
-
Olivier F. BertrandRecruitingBifurcation Coronary Disease | Restenosis, Coronary | Coronary Arterial Disease (CAD)Canada
-
Ceric SàrlEuropean Cardiovascular Research Center; Philips Medical SystemsNot yet recruitingStable Coronary Artery Disease | Acute Coronary Syndromes
-
Cardiocentro TicinoNot yet recruitingMultivessel Coronary Artery Disease | Coronary Vessel | Acute Coronary Syndromes (ACS) | Vulnerable Coronary Plaques | Coronary Arterial Disease (CAD)Switzerland
Clinical Trials on Treadmill aerobic exercise without water intake
-
Universidade Estadual Paulista Júlio de Mesquita...Completed
-
Faculdade de Ciências Médicas da Santa Casa de...Fundação de Amparo à Pesquisa do Estado de São Paulo; Coordenação de Aperfeiçoamento...CompletedScoliosis | Adolescent ScoliosisBrazil
-
Bezmialem Vakif UniversityRecruiting
-
University of PittsburghUniversity of Pittsburgh Medical CenterTerminatedSport Injury | Concussion, MildUnited States
-
Coventry UniversityBritish Society for Research on AgeingCompletedAging | Physical InactivityUnited Kingdom
-
Riphah International UniversityCompleted
-
Lincoln University CollegeWuhan Technical UniversityCompletedSelf-Perception | Mental Fatigue | Psychological Stress | Autonomic Nervous System Function | Post-Exercise Recovery | Healthy University StudentsChina
-
University of ZurichNot yet recruiting
-
Instituto de Cardiologia do Rio Grande do SulCompleted
-
Old Dominion UniversityCompletedPhysical Activity | Exercise | Healthy Adult | Interoception | Affect and Exertion During and Post-exerciseUnited States